Total liabilities · 2015–2025
Syndax Pharmaceuticals total liabilities
$465M+6.5% · FY2025
Syndax Pharmaceuticals (SNDX) reported $465M in total liabilities for fiscal 2025, +6.5% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $465M | +6.5% | Open → |
| FY20242024-12-31 | $437M | +644.1% | Open → |
| FY20232023-12-31 | $58.7M | +97.0% | Open → |
| FY20222022-12-31 | $29.8M | −27.9% | Open → |
| FY20212021-12-31 | $41.3M | −14.7% | Open → |
| FY20202020-12-31 | $48.4M | +51.7% | Open → |
| FY20192019-12-31 | $31.9M | +3.3% | Open → |
| FY20182018-12-31 | $30.9M | −6.0% | Open → |
| FY20172017-12-31 | $32.9M | +32.1% | Open → |
| FY20162016-12-31 | $24.9M | +7.2% | Open → |
| FY20152015-12-31 | $23.2M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +35.0%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Syndax Pharmaceuticals total liabilities |url=https://companiesranked.com/en/company/syndax-pharmaceuticals/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Syndax Pharmaceuticals total liabilities. CompaniesRanked. https://companiesranked.com/en/company/syndax-pharmaceuticals/total-liabilitiesBibTeX
@misc{companiesranked-en-company-syndax-pharmaceuticals-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Syndax Pharmaceuticals total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/syndax-pharmaceuticals/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-332750 · August 4, 2026
{{cite web |title=Syndax Pharmaceuticals total liabilities — 10-Q (0001193125-26-332750) |url=https://www.sec.gov/Archives/edgar/data/1395937/000119312526332750/sndx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.